Replies to post #28580 on Marker Therapeutics Inc (MRKR)

[poods]

Thanks so much. Makes perfect sense. Of course, in a perfect world, CAR-T would be reserved for Multi-TAA failures, based on cost and durable response rates along with side effects. If i was a patient, I'd take the multi-TAA first and have the CAR-T ready to go (ideally an off the shelf product which are in development). I'm guessing that may be where this eventually ends up (maybe even both delivered together).
Thanks again for getting this info. Very reassuring!

[poods]

PS They may need to go to Europe or Australia where they don't want to pay for Yescarta. Sooner the better. Get a partner and get it done. Easy to throw out ideas from the sidelines.